Contribution of different HFE genotypes to iron overload disease: a pooled analysis

Purpose: To determine the contribution of the C282Y and H63D mutations in the HFE gene to clinical expression of hereditary hemochromatosis.Methods: Pooled analysis of 14 case-control studies reporting HFE genotype data, to evaluate the association of different HFE genotypes with iron overload. In addition, we used data from the pooled analysis and published data to estimate the penetrance of the C282Y/C282Y genotype.Results: Homozygosity for the C282Y mutation carried the largest risk for iron overload (OR = 4383, 95% Cl 1374 to >10,000) and accounted for the majority of hemochromatosis cases (attributable fraction (AF) = 0.73). Risks for other genotypes were much smaller: OR = 32 for genotype C282Y/H63D (95% Cl 18.5 to 55.4, AF = 0.06); OR = 5.7 for H63D/H63D (95% Cl 3.2 to 10.1, AF = 0.01); OR = 4.1 for C282Y heterozygosity (95% Cl 2.9 to 5.8, with heterogeneity in study results, making this association uncertain); and OR = 1.6 for H63D heterozygosity (95% Cl 1 to 2.6, AF = 0.03). Estimates of penetrance for the C282Y/C282Y genotype were highly sensitive to estimates of the prevalence of iron overload disease. At a prevalence of 2.5 per 1000 or less, penetrance of the C282Y/C282Y genotype is unlikely to exceed 50%. Penetrance of other HFE genotypes is much lower.Conclusions: C282Y homozygosity confers the highest risk for iron overload but the H63D mutation is also associated with increased risk. Our data indicate a gradient of risk associated with different HFE genotypes and thus suggest the presence of other modifiers, either genetic or environmental, that contribute to the clinical expression of hemochromatosis.

[1]  P. Adams.  Population screening for haemochromatosis , 2000, Gut.

[2]  J. J. Pointon,et al.  Polymorphism in intron 4 of HFE does not compromise haemochromatosis mutation results , 1999, Nature Genetics.

[3]  R. Ries,et al.  Polymorphism in intron 4 of HFE does not compromise haemochromatosis mutation results , 1999, Nature Genetics.

[4]  J. Olynyk,et al.  A population-based study of the clinical expression of the hemochromatosis gene. , 1999, The New England journal of medicine.

[5]  M. Somerville,et al.  An HFE intronic variant promotes misdiagnosis of hereditary hemochromatosis. , 1999, American journal of human genetics.

[6]  R. Hegele,et al.  Polymorphism in intron 4 of HFE may cause overestimation of C282Y homozygote prevalence in haemochromatosis , 1999, Nature Genetics.

[7]  M. Cogswell,et al.  Population-based screening for hemochromatosis using phenotypic and DNA testing among employees of health maintenance organizations in Springfield, Missouri. , 1999, The American journal of medicine.

[8]  P. Adams.  Population screening for hemochromatosis , 1999, Hepatology.

[9]  J. L. Le Gall,et al.  Phenotypic expression of HFE mutations: a French study of 1110 unrelated iron-overloaded patients and relatives. , 1999, Gastroenterology.

[10]  J. Berg,et al.  High prevalence of the hemochromatosis-associated Cys282Tyr HFE gene mutation in a healthy Norwegian population in the city of Oslo, and its phenotypic expression. , 1999, Scandinavian journal of gastroenterology.

[11]  T. Löffler,et al.  HFE codon 63/282 (H63D/C282Y) dimorphism in German patients with genetic hemochromatosis. , 2008, Tissue antigens.

[12]  C. Frampton,et al.  The significance of haemochromatosis gene mutations in the general population: implications for screening , 1998 .

[13]  R. G. Parrish,et al.  Hemochromatosis-Associated Mortality in the United States from 1979 to 1992: An Analysis of Multiple-Cause Mortality Data , 1998, Annals of Internal Medicine.

[14]  M. Khoury,et al.  Iron Overload, Public Health, and Genetics: Evaluating the Evidence for Hemochromatosis Screening , 1998, Annals of Internal Medicine.

[15]  M. O'Leary,et al.  Prevalence of Hereditary Hemochromatosis in 16 031 Primary Care Patients , 1998, Annals of Internal Medicine.

[16]  Mayka Sánchez,et al.  Prevalence of the Cys282Tyr and His63Asp HFE gene mutations in Spanish patients with hereditary hemochromatosis and in controls , 1998 .

[17]  D. Middleton,et al.  High incidence of the Cys 282 Tyr mutation in the HFE gene in the Irish population--implications for haemochromatosis. , 1998, Tissue antigens.

[18]  P. Adams.  Hemochromatosis: clinical implications of genetic testing. , 1998, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[19]  D. Girelli,et al.  Heterogeneity of hemochromatosis in Italy. , 1998, Gastroenterology.

[20]  J. Haddow,et al.  Hereditary haemochromatosis mutation frequencies in the general population , 1998, Journal of medical screening.

[21]  Esin,et al.  HFE mutations in patients with hereditary haemochromatosis in Sweden , 1998, Journal of internal medicine.

[22]  D. M. Penny,et al.  The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[23]  R. Oliva,et al.  Prevalence of the Cys282Tyr and His63Asp HFE gene mutations in Spanish patients with hereditary hemochromatosis and in controls. , 1998, Journal of hepatology.

[24]  J. Kushner,et al.  Screening for hemochromatosis: phenotype versus genotype. , 1998, Seminars in hematology.

[25]  Roger Williams,et al.  A simple genetic test identifies 90% of UK patients with haemochromatosis , 1997, Gut.

[26]  W. Sly,et al.  Hereditary hemochromatosis: effects of C282Y and H63D mutations on association with beta2-microglobulin, intracellular processing, and cell surface expression of the HFE protein in COS-7 cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[27]  P. Meier,et al.  Identification and functional characterization of the promoter region of the human organic anion transporting polypeptide gene , 1997, Hepatology.

[28]  V. David,et al.  Clinical and family studies in genetic hemochromatosis: Microsatellite and HFE studies in five atypical families , 1997, Hepatology.

[29]  B. Bacon.  Diagnosis and management of hemochromatosis. , 1997, Gastroenterology.

[30]  R. Wolff,et al.  The Hemochromatosis Founder Mutation in HLA-H Disrupts β2-Microglobulin Interaction and Cell Surface Expression* , 1997, The Journal of Biological Chemistry.

[31]  B. Bacon,et al.  Hereditary hemochromatosis: presentation and diagnosis in the 1990s. , 1997, The American journal of gastroenterology.

[32]  J. Barton,et al.  Genetic and clinical description of hemochromatosis probands and heterozygotes: evidence that multiple genes linked to the major histocompatibility complex are responsible for hemochromatosis. , 1997, Blood cells, molecules & diseases.

[33]  J. Bodmer,et al.  Putting a hold on ‘HLA–H’ , 1997, Nature Genetics.

[34]  C. Férec,et al.  Putting a hold on ‘HLA–H’ , 1997, Nature Genetics.

[35]  J. Vinel,et al.  Mutations in the MHC class I-like candidate gene for hemochromatosis in French patients , 1997, Immunogenetics.

[36]  J. Haddow,et al.  Population Screening for Haemochromatosis: A Unifying Analysis of Published Intervention Trials , 1996, Journal of medical screening.

[37]  C. P. Morris,et al.  Haemochromatosis and HLA–H , 1996, Nature Genetics.

[38]  P. Fergelot,et al.  Haemochromatosis and HLA–H , 1996, Nature Genetics.

[39]  C. Venditti,et al.  Mutation analysis in hereditary hemochromatosis. , 1996, Blood cells, molecules & diseases.

[40]  M. C. Ellis,et al.  A novel MHC class I–like gene is mutated in patients with hereditary haemochromatosis , 1996, Nature Genetics.

[41]  J. Gregor,et al.  Screening blood donors for hereditary hemochromatosis: decision analysis model based on a 30-year database. , 1995, Gastroenterology.

[42]  J. L. Simons,et al.  Hemochromatosis screening in asymptomatic ambulatory men 30 years of age and older. , 1995, The American journal of medicine.

[43]  M. Burritt,et al.  Screening for hemochromatosis: a cost-effectiveness study based on 12,258 patients. , 1994, Gastroenterology.

[44]  B. Lin,et al.  Prevalence of hemochromatosis in a random sample of asymptomatic men. , 1986, Australian and New Zealand journal of medicine.